Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials. Wells JC, Sidhu A, Ding K, Smoragiewicz M, et al. Oncologist 2022;27:e286-e293.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wells JC, Sidhu A, Ding K, Smoragiewicz M, et al. Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials. Oncologist 2022;27:e286-e293.
PMID: 35274718